BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jilek JL, Zhang QY, Tu MJ, Ho PY, Duan Z, Qiu JX, Yu AM. Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal Immunogenicity. Mol Ther Nucleic Acids 2019;14:498-508. [PMID: 30753993 DOI: 10.1016/j.omtn.2019.01.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Traber GM, Yu AM. RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies. J Pharmacol Exp Ther 2023;384:133-54. [PMID: 35680378 DOI: 10.1124/jpet.122.001234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
2 Liu Y, Su C, Yan Y, Wang J, Li J, Fu J, Wang Y, Zhang J. Exosomes of A549 Cells Induced Migration, Invasion, and EMT of BEAS-2B Cells Related to let-7c-5p and miR-181b-5p. Front Endocrinol 2022;13:926769. [DOI: 10.3389/fendo.2022.926769] [Reference Citation Analysis]
3 Liu X, Zeng W, Zheng D, Tang M, Zhou W. Let-7c-5p Restrains Cell Growth and Induces Apoptosis of Lung Adenocarcinoma Cells via Targeting ESPL1. Mol Biotechnol 2022. [PMID: 35639278 DOI: 10.1007/s12033-022-00511-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yi WR, Tu MJ, Yu AX, Lin J, Yu AM. Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions. Bioengineered 2022;13:12489-503. [PMID: 35579419 DOI: 10.1080/21655979.2022.2076399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tu M, Yi CM, Traber GM, Yu A. Bioengineered RNA Therapy in Patient-Derived Organoids and Xenograft Mouse Models. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2441-8_10] [Reference Citation Analysis]
6 Jerzykiewicz J, Czogalla A. Polyethyleneimine-Based Lipopolyplexes as Carriers in Anticancer Gene Therapies. Materials (Basel) 2021;15:179. [PMID: 35009324 DOI: 10.3390/ma15010179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Deng L, Petrek H, Tu MJ, Batra N, Yu AX, Yu AM. Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo. Acta Pharm Sin B 2021;11:3950-65. [PMID: 35024318 DOI: 10.1016/j.apsb.2021.07.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Zhang R, Liu P, Zhang X, Ye Y, Yu J. Lin28A promotes the proliferation and stemness of lung cancer cells via the activation of mitogen-activated protein kinase pathway dependent on microRNA let-7c. Ann Transl Med 2021;9:982. [PMID: 34277782 DOI: 10.21037/atm-21-2124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Petrek H, Yan Ho P, Batra N, Tu MJ, Zhang Q, Qiu JX, Yu AM. Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growth. Biochem Pharmacol 2021;189:114392. [PMID: 33359565 DOI: 10.1016/j.bcp.2020.114392] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
10 Tu MJ, Wright HK, Batra N, Yu AM. Expression and Purification of tRNA/ pre-miRNA-Based Recombinant Noncoding RNAs. Methods Mol Biol 2021;2323:249-65. [PMID: 34086286 DOI: 10.1007/978-1-0716-1499-0_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Tian Y, Yin C, Yang C, Ji M, Chu X, Qian A. Synthetic Technology of Noncoding RNAs Used in Bone Disease Research and Therapeutics. Noncoding RNAs and Bone 2021. [DOI: 10.1007/978-981-16-2402-5_7] [Reference Citation Analysis]
12 Yousef MH, El-Fawal HAN, Abdelnaser A. Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma. Biomed Res Int 2020;2020:9593254. [PMID: 33299889 DOI: 10.1155/2020/9593254] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
13 Li Y, Li P, Wang N. Effect of let-7c on the PI3K/Akt/FoxO signaling pathway in hepatocellular carcinoma. Oncol Lett 2021;21:96. [PMID: 33376529 DOI: 10.3892/ol.2020.12357] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
14 Hashemi A, Gorji-Bahri G. MicroRNA: Promising Roles in Cancer Therapy. Curr Pharm Biotechnol 2020;21:1186-203. [PMID: 32310047 DOI: 10.2174/1389201021666200420101613] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
15 Jilek JL, Tu MJ, Zhang C, Yu AM. Pharmacokinetic and Pharmacodynamic Factors Contribute to Synergism between Let-7c-5p and 5-Fluorouracil in Inhibiting Hepatocellular Carcinoma Cell Viability. Drug Metab Dispos 2020;48:1257-63. [PMID: 33051247 DOI: 10.1124/dmd.120.000207] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
16 Tu MJ, Duan Z, Liu Z, Zhang C, Bold RJ, Gonzalez FJ, Kim EJ, Yu AM. MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis. Mol Pharmacol 2020;98:686-94. [PMID: 33051382 DOI: 10.1124/molpharm.120.000130] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
17 Yu AM, Choi YH, Tu MJ. RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges. Pharmacol Rev 2020;72:862-98. [PMID: 32929000 DOI: 10.1124/pr.120.019554] [Cited by in Crossref: 89] [Cited by in F6Publishing: 106] [Article Influence: 29.7] [Reference Citation Analysis]
18 Laham-Karam N, Pinto GP, Poso A, Kokkonen P. Transcription and Translation Inhibitors in Cancer Treatment. Front Chem 2020;8:276. [PMID: 32373584 DOI: 10.3389/fchem.2020.00276] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
19 Li DF, Yuan Y, Tu MJ, Hu X, Li YZ, Yi WR, Li PC, Zhao Y, Cheng Z, Yu AM, Jian C, Yu AX. The Optimal Outcome of Suppressing Ewing Sarcoma Growth in vivo With Biocompatible Bioengineered miR-34a-5p Prodrug. Front Oncol 2020;10:222. [PMID: 32161722 DOI: 10.3389/fonc.2020.00222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
20 Yu AM, Batra N, Tu MJ, Sweeney C. Novel approaches for efficient  in vivo fermentation production of noncoding RNAs. Appl Microbiol Biotechnol 2020;104:1927-37. [PMID: 31953559 DOI: 10.1007/s00253-020-10350-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
21 Fornari F, Gramantieri L, Callegari E, Shankaraiah RC, Piscaglia F, Negrini M, Giovannini C. MicroRNAs in Animal Models of HCC. Cancers (Basel) 2019;11:E1906. [PMID: 31805631 DOI: 10.3390/cancers11121906] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
22 Li Y, Meng Q, Yang M, Liu D, Hou X, Tang L, Wang X, Lyu Y, Chen X, Liu K, Yu AM, Zuo Z, Bi H. Current trends in drug metabolism and pharmacokinetics. Acta Pharm Sin B 2019;9:1113-44. [PMID: 31867160 DOI: 10.1016/j.apsb.2019.10.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 74] [Article Influence: 16.5] [Reference Citation Analysis]
23 Ning B, Yu D, Yu AM. Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics. Biochem Pharmacol 2019;169:113638. [PMID: 31518552 DOI: 10.1016/j.bcp.2019.113638] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
24 Duan S, Li J, Tian J, Yin H, Zhai Q, Wu Y, Yao S, Zhang L. Crosstalk between let-7a-5p and BCL-xL in the Initiation of Toxic Autophagy in Lung Cancer. Mol Ther Oncolytics 2019;15:69-78. [PMID: 31650027 DOI: 10.1016/j.omto.2019.08.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
25 Petrek H, Batra N, Ho PY, Tu MJ, Yu AM. Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs. Appl Microbiol Biotechnol 2019;103:6107-17. [PMID: 31187211 DOI: 10.1007/s00253-019-09934-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
26 Liu Z, Tu MJ, Zhang C, Jilek JL, Zhang QY, Yu AM. A reliable LC-MS/MS method for the quantification of natural amino acids in mouse plasma: Method validation and application to a study on amino acid dynamics during hepatocellular carcinoma progression. J Chromatogr B Analyt Technol Biomed Life Sci 2019;1124:72-81. [PMID: 31177050 DOI: 10.1016/j.jchromb.2019.05.039] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]